Related Experiment Video
Updated: Jun 6, 2025
09:24
Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
9.0K
The CDK12-BRCA1 signaling axis mediates dinaciclib-associated radiosensitivity through p53-mediated cellular
Natalia García Flores1,2, Diego M Fernández-Aroca1,2,3, Cristina Garnés-García1,2,4
1Laboratorio de Oncología Molecular, Unidad de Medicina Molecular, Instituto de Biomedicina, Universidad de Castilla-La Mancha, Albacete, Spain.
Molecular Oncology
|December 3, 2024
Summary
Dinaciclib enhances radiosensitivity in certain cancers by inhibiting CDK12 and affecting DNA repair pathways. This finding supports personalized cancer therapy based on tumor genetics.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Pan-cyclin-dependent-kinase (CDK) inhibitors, like dinaciclib, represent a novel targeted therapy class.
- Combining dinaciclib with radiotherapy is an underexplored therapeutic strategy.
Purpose of the Study:
- To investigate the efficacy of combining dinaciclib with ionizing radiation in experimental cancer models.
- To elucidate the molecular mechanisms underlying dinaciclib's effect on radiosensitivity.
Main Methods:
- Treatment of lung and colon cancer cell lines (A549, HCT 116, H1299, HT-29) with dinaciclib and ionizing radiation.
- Analysis of DNA damage signaling (ATM), cell cycle progression, apoptosis, and DNA repair pathways (HR, NHEJ).
- Assessment of BRCA1 expression and its role in radiosensitization.
Main Results:
- Dinaciclib increased radiosensitivity in A549 and HCT 116 cells, but not in H1299 or HT-29 cells.
- The combination did not alter ATM signaling or cell cycle profiles post-irradiation.
- Dinaciclib inhibited CDK12, reducing BRCA1 expression, impairing homologous recombination (HR), and promoting senescence in a TP53-dependent manner.
Conclusions:
- The CDK12-BRCA1 axis mediates dinaciclib's radiosensitizing effect, impacting DNA repair pathways.
- This mechanism explains differential responses to dinaciclib and radiotherapy based on tumor genetic profiles.
- Findings support personalized radiotherapy strategies tailored to individual tumor characteristics.
Related Concept Videos
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K